0 results available. Select is focused ,type to refine list, press Down to open the menu,
Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...
The following section summarizes insights on Novartis AG ADR's P/E Ratio (Adjusted):
We've identified the following companies as similar to Novartis AG ADR because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
Data is returned as a standard number. Suggested format is a multiple (e.g 7.0x). Please note, you need a Premium subscription to access data for pe_ltm_adj.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to P/E Ratio (Adjusted) in the valuation category include:
Indicates the multiple of earnings, adjusted for usual items, that stock investors are willing to pay for one share of the firm.
No data available
The chart above depicts the distribution of p/e ratio (adjusted) for companies operating in the Healthcare sector in the Developed economic region. Over 2,460 companies were considered in this analysis, and 2,363 had meaningful values. The average p/e ratio (adjusted) of companies in the sector is 0.4x with a standard deviation of 19.6x.
Novartis AG ADR's P/E Ratio (Adjusted) of 15.4x ranks in the 84.1% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,461 |
| Included Constituents | 2,363 |
| Min | -98.6x |
| Max | 84.4x |
| Median | -1.4x |
| Mean | 0.4x |
| Standard Deviation | 19.6x |
You can find companies with similar p/e ratio (adjusted) using this stock screener.